Free Access
Issue
Med Sci (Paris)
Volume 28, Number 3, Mars 2012
Page(s) 248 - 250
Section Nouvelles
DOI https://doi.org/10.1051/medsci/2012283007
Published online 06 April 2012
  1. Kakizuka A, Miller WH Jr, Umesono K, et al. Chromosomal translocation t(15;17) in human acute promyelocytic leukemia fuses RAR alpha with a novel putative transcription factor, PML. Cell 1991 ; 66 : 663–674. [CrossRef] [PubMed] [Google Scholar]
  2. De Thé H, Lavau C, Marchio A, et al. The PML-RAR alpha fusion mRNA generated by the t(15;17) translocation in acute promyelocytic leukemia encodes a functionally altered RAR. Cell 1991 ; 66 : 675–684. [CrossRef] [PubMed] [Google Scholar]
  3. Brondello JM, Prieur A, Philippot D, et al. La sénescence cellulaire : un nouveau mythe de Janus ?. Med Sci (Paris) 2012 ; 28 : 288–296. [CrossRef] [EDP Sciences] [PubMed] [Google Scholar]
  4. Wang ZG, Delva L, Gaboli M, et al. Role of PML in cell growth and the retinoic acid pathway. Science 1998 ; 279 : 1547–1551. [CrossRef] [PubMed] [Google Scholar]
  5. Ferbeyre G, de Stanchina E, Querido E, et al. PML is induced by oncogenic ras and promotes premature senescence. Genes Dev 2000 ; 14 : 2015–2027. [Google Scholar]
  6. Pearson M, Carbone R, Sebastiani C, et al. PML regulates p53 acetylation and premature senescence induced by oncogenic Ras. Nature 2000 ; 406 : 207–210. [CrossRef] [PubMed] [Google Scholar]
  7. Bischof O, Kirsh O, Pearson M, et al. Deconstructing PML-induced premature senescence. EMBO J 2002 ; 21 : 3358–3369. [CrossRef] [PubMed] [Google Scholar]
  8. De Stanchina E, Querido E, Narita M, et al. PML is a direct p53 target that modulates p53 effector functions. Mol Cell 2004 ; 13 : 523–535. [CrossRef] [PubMed] [Google Scholar]
  9. Vernier M, Bourdeau V, Gaumont-Leclerc MF, et al. Regulation of E2Fs and senescence by PML nuclear bodies. Genes Dev 2011 ; 25 : 41–50. [Google Scholar]
  10. Martin N, Benhamed M, Nacerddine K, et al. Physical and functional interaction between PML and TBX2 in the establishment of cellular senescence. EMBO J 2012 ; 31 : 95–109. [CrossRef] [PubMed] [Google Scholar]
  11. Jacobs JJ, Keblusek P, Robanus-Maandag E, et al. Senescence bypass screen identifies TBX2, which represses Cdkn2a (p19(ARF)) and is amplified in a subset of human breast cancers. Nat Genet 2000 ; 26 : 291–299. [CrossRef] [PubMed] [Google Scholar]
  12. Abrahams A, Parker MI, Prince S. The T-box transcription factor Tbx2: its role in development and possible implication in cancer. IUBMB Life 2010 ; 62 : 92–102. [PubMed] [Google Scholar]
  13. Gurrieri C, Capodieci P, Bernardi R, et al. Loss of the tumor suppressor PML in human cancers of multiple histologic origins. J Natl Cancer Inst 2004 ; 96 : 269–279. [CrossRef] [PubMed] [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.